DUBLIN, Ohio - Cardinal Health on Monday reported $31.4 billion in revenue for its fiscal 2016 second quarter, representing an increase of 23%.
"Our performance in the second quarter of our fiscal 2016 reflects our deep commitment to serving a health system experiencing powerful changes," stated George Barrett, chairman and CEO Cardinal Health. "We achieved strong revenue and operating growth. Both of our reporting segments continue to demonstrate very solid fundamentals and growth in our base of customers."
Second-quarter revenue for Cardinal Health's Pharmaceutical segment increased 25% to $28.3 billion thanks to growth from existing and new customers as well as acquisitions.
Barrett noted that the company was reaffirming its fiscal 2016 non-GAAP diluted earnings per share guidance of $5.15 to $5.35, representing an 18% to 22% growth rate compared to fiscal 2015.